Levosimendan Administration in Pulmonary Hypertension

NCT04599816 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Hypertension, Pulmonary
Cardiac Failure
Pulmonary Vascular Resistance Abnormality

Interventions

DRUG: levosimendan at a dose of 3 mcg/kg
DRUG: levosimendan at a dose of 6 mcg/kg
DRUG: levosimendan at a dose of 12 mcg/kg

Sponsor

Aretaieion University Hospital